Sanofi to acquire Genzyme for $20.1 Billion
Nine months of relentless pursuit seems to have paid off, with the French pharmaceutical giant, Sanofi-Aventis, being just hours away to finally acquiring U.S. contemporary Genzyme
Nine months of relentless pursuit seems to have paid off, with the French pharmaceutical giant, Sanofi-Aventis, being just hours away to finally acquiring U.S. contemporary Genzyme